Results
1
1 companies
argenx
Market Cap: €47.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€782.40
7D
-2.2%
1Y
33.4%
